2024 |
Agilent Technologies Inc.
|
Independent Director |
362.5 K |
6.0 % |
2023 |
Agilent Technologies Inc.
|
Independent Director |
341.8 K |
-4.4 % |
2022 |
Agilent Technologies Inc.
|
Independent Director |
357.6 K |
216.5 % |
2021 |
Karyopharm Therapeutics Inc
|
- |
206.9 K |
-22.3 % |
2021 |
Agilent Technologies Inc.
|
Independent Director |
113.0 K |
- |
2021 |
Karyopharm Therapeutics Inc
|
Independent Director |
- |
- |
2020 |
Karyopharm Therapeutics Inc
|
Independent Director |
266.5 K |
86.7 % |
2019 |
Karyopharm Therapeutics Inc
|
Independent Director |
142.7 K |
-46.5 % |
2018 |
Karyopharm Therapeutics Inc
|
Independent Director |
266.6 K |
74.0 % |
2017 |
Karyopharm Therapeutics Inc
|
Independent Director |
153.2 K |
65.0 % |
2016 |
Karyopharm Therapeutics Inc
|
Independent Director |
92.9 K |
-85.2 % |
2015 |
Karyopharm Therapeutics Inc
|
Independent Director |
629.2 K |
- |
2014 |
Karyopharm Therapeutics Inc
|
Independent Director |
- |
- |